KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 78 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $296,508 | +17.3% | 30,790 | +9.6% | 0.01% | +16.7% |
| Q2 2023 | $252,882 | +14.5% | 28,098 | 0.0% | 0.01% | +20.0% |
| Q1 2023 | $220,850 | -9.9% | 28,098 | +100.2% | 0.01% | -28.6% |
| Q3 2021 | $245,000 | -39.4% | 14,036 | -16.7% | 0.01% | -46.2% |
| Q2 2021 | $404,000 | -52.2% | 16,856 | -48.7% | 0.01% | -59.4% |
| Q1 2021 | $845,000 | -60.8% | 32,875 | -71.0% | 0.03% | -60.0% |
| Q4 2020 | $2,156,000 | +29.9% | 113,533 | -13.9% | 0.08% | -20.0% |
| Q3 2020 | $1,660,000 | +9.9% | 131,822 | +5.5% | 0.10% | -2.9% |
| Q2 2020 | $1,511,000 | +82.0% | 124,902 | +15.1% | 0.10% | +49.3% |
| Q1 2020 | $830,000 | +6.5% | 108,492 | +148.0% | 0.07% | +1.5% |
| Q4 2019 | $779,000 | +125.1% | 43,749 | +46.7% | 0.07% | +112.5% |
| Q3 2019 | $346,000 | +137.0% | 29,825 | +37.7% | 0.03% | +33.3% |
| Q3 2017 | $146,000 | -8.2% | 21,665 | 0.0% | 0.02% | -27.3% |
| Q2 2017 | $159,000 | -5.9% | 21,665 | 0.0% | 0.03% | +6.5% |
| Q1 2017 | $169,000 | +45.7% | 21,665 | +32.5% | 0.03% | +19.2% |
| Q4 2016 | $116,000 | – | 16,346 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $13,155,000 | 11.03% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $2,974,000 | 3.14% |
| Vivo Capital, LLC | 1,476,796 | $11,297,000 | 1.02% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 227,433 | $1,731,000 | 0.79% |
| DAFNA Capital Management LLC | 234,952 | $1,797,000 | 0.75% |
| Samsara BioCapital, LLC | 168,174 | $1,287,000 | 0.74% |
| Ghost Tree Capital, LLC | 350,000 | $2,678,000 | 0.71% |
| Ikarian Capital, LLC | 946,605 | $7,242,000 | 0.54% |
| Opaleye Management Inc. | 225,000 | $1,721,000 | 0.46% |
| Eventide Asset Management | 1,680,000 | $12,852,000 | 0.42% |